Altimmune (ALT) FCF Margin (2010 - 2025)
Altimmune (ALT) posted quarterly FCF Margin of 74803.85% for Q4 2025, up 29049615.0% year-over-year from N/an in Q4 2024, and up 68.56% quarter-over-quarter from 237940.0% in Q3 2025.
Altimmune (ALT) FCF Margin (2010 - 2025) Analysis & Trends
Altimmune (ALT) has reported FCF Margin for 16 consecutive years, with 74803.85% the latest figure, recorded in Q4 2025.
- In Q4 2025, FCF Margin rose 29049615.0% year-over-year to 74803.85%; the TTM figure through Dec 2025 stood at 164721.95% (up 23451805.0% YoY), while the FY2025 annual figure was 164746.34%, up 23449366.0% from the prior year.
- FCF Margin advanced to 74803.85% in Q4 2025 per ALT's latest filing, from 237940.0% in the prior quarter.
- Across five years, FCF Margin topped out at 674.82% in Q4 2021 and bottomed at 755500.0% in Q3 2022.
- Historically, FCF Margin has averaged 210363.27% across 5 years, with a median of 150847.32% in 2023.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 74420570 bps — and 2023, when it soared 74984061 bps.
- Altimmune's FCF Margin stood at 674.82% in 2021, then sank by 9785 bps to 66707.69% in 2022, then jumped by 33 bps to 44683.78% in 2023, then tumbled by 718 bps to 365300.0% in 2024, then surged by 80 bps to 74803.85% in 2025.
- Business Quant data shows ALT's FCF Margin at 74803.85% in Q4 2025, 237940.0% in Q3 2025, and 387000.0% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -74,803.85% |
| Sep 30, 2025 | -237,940.00% |
| Jun 30, 2025 | -387,000.00% |
| Mar 31, 2025 | -336,800.00% |
| Dec 31, 2024 | -365,300.00% |
| Sep 30, 2024 | -542,360.00% |
| Jun 30, 2024 | -362,160.00% |
| Mar 31, 2024 | -327,140.00% |
| Dec 31, 2023 | -44,683.78% |
| Sep 30, 2023 | -5,659.39% |
| Jun 30, 2023 | -322,983.33% |
| Mar 31, 2023 | -92,657.14% |
| Dec 31, 2022 | -66,707.69% |
| Sep 30, 2022 | -755,500.00% |
| Jun 30, 2022 | -209,037.50% |
| Mar 31, 2022 | -42,296.88% |
| Dec 31, 2021 | -674.82% |
| Sep 30, 2021 | -11,294.30% |
| Jun 30, 2021 | -19,429.20% |
| Mar 31, 2021 | -2,837.47% |